Opening soon. Stay in the loop

goodmorrowJoin the opening list

Melanotan II, explained.

Research, safety questions, and treatment context.

Updated Clinical review pending · Educational draft

The form

Pharmacy catalog form

The routine

No established safe cosmetic tanning schedule can be drawn from this pilot.

The evidence

Very small early human studies

Forms listed in a June 2025 catalog. Current availability and individual instructions need confirmation.

Legal status
Awaiting FDA review

Came off the FDA's restricted list in April 2026 only because its nomination was withdrawn. An FDA review is due by February 2027.

At Goodmorrow
Not offered

What it is

Melanotan II is a synthetic version of alpha-MSH, the hormone that darkens skin. PT-141 (bremelanotide) was developed from it.

What the evidence shows

It does darken skin. It also causes nausea, flushing and unwanted erections, and dermatologists have reported new or changing moles in people who use it.

How Goodmorrow handles it

Not offered, and we don't expect that to change.

Questions people ask

Is Melanotan II legal now that it's off the restricted list?

No. Coming off the restricted list didn't put it on the allowed list. The FDA plans to review it before the end of February 2027.

Sources

  1. Secondary sourceFDA Peptide Update 2026: Removal from the Do Not Compound List Frier Levitt, August 2026
  2. Secondary sourceThe US Peptide Status Index Peptide America

Good days ahead.

Join the opening list for appointment updates.

Join the opening list